Kanagawa, Japan

Tatsuya Tomiyama

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Peptidream Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tatsuya Tomiyama. Retrieved from https://idiyas.com/inventor/tatsuya-tomiyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tatsuya Tomiyama: Innovator in Peptide Technology

Introduction

Tatsuya Tomiyama is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of peptide technology, particularly in relation to growth hormone receptors.

Latest Patents

Tomiyama holds a patent for a GhR-binding peptide and composition comprising the same. This technology relates to peptides that bind to the growth hormone receptor (GhR) and includes peptides with antagonistic activity, as well as compositions that incorporate these peptides.

Career Highlights

He is currently associated with Peptidream Inc., a company known for its innovative approaches in peptide drug discovery. His work has been instrumental in advancing the understanding and application of peptide technology in therapeutic contexts.

Collaborations

One of his notable coworkers is Katsuma Matsui, with whom he has likely collaborated on various projects within the realm of peptide research.

Conclusion

Tatsuya Tomiyama's contributions to peptide technology, particularly through his patent on GhR-binding peptides, highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…